Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
Group 2 innate lymphoid cells (ILC2s) modulate inflammatory and allergic responses, but their function in cancer immunity is still unclear. Here the authors show that, in acute promyelocytic leukaemia, tumour-activated ILC2s secrete IL-13 to induce myeloid-derived suppressor cells and support tumour...
Enregistré dans:
Documents similaires
-
Host STING-dependent MDSC mobilization drives extrinsic radiation resistance
par: Hua Liang, et autres
Publié: (2017) -
A reduced-order method with PGD for the analysis of misaligned journal bearing
par: Megdoud Abdelhak, et autres
Publié: (2021) -
Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC
par: Lilv Fan, et autres
Publié: (2021) -
6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function
par: Saeed Daneshmandi, et autres
Publié: (2021) -
A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth
par: Joanna L Gillis, et autres
Publié: (2021)